Cardiopulmonary Sciences
Chronic obstructive pulmonary disease is connected with expanded danger of cardiovascular illness, for example, heart failure or a heart attack. The lungs and the heart work firmly together to supply the oxygen; oxygen noticeable all around comes into the lungs is moved into the dissemination framework, which the heart by then pushes out the oxygen to rest of the body. Be that as it may, maladies in both the heart and the lungs normally go together. On the off chance that individual has COPD by then there is a higher danger of having cardiovascular ailments. Comorbidities and incessant obstructive aspiratory sickness (COPD) are inescapable, with cardiovascular infection being the most outstanding and critical. Hazard factors for COPD and Cardiovascular Diseases, for example, smoking, low financial class, and a stationary lifestyle add to the regular history of every one of these conditions. COPD Conferences will concentrate on the extent of COPD identified with cardiovascular diseases.
- Respiratory therapist.
- Cardiovascular invasive specialist.
- Cardiovascular technologist
- Vascular technologist
Related Conference of Cardiopulmonary Sciences
15th International Conference on Pulmonary & Respiratory Medicine
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Cardiopulmonary Sciences Conference Speakers
Recommended Sessions
- Pulmonary Rehabilitation
- Advances in Respiratory Medicine
- Asthma and Allergy
- Cardiopulmonary Sciences
- Chronic Obstructive Pulmonary Disease
- Lung Cancer Screening, Diagnosis & Treatment
- Lung Transplantation
- Pediatric Pulmonology & Critical care
- Pulmonary Hypertension
- Respiratory and Pulmonary Therapies
- Respiratory Tract Infections
- Severe Acute Respiratory Syndrome (SARS)
- Tuberculosis
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)